VACCINEX, INC. cotiza a 1.12 USD y tiene una capitalización bursátil de $3M. En los últimos 12 meses ha facturado $601000 con un margen de flujo de caja libre del -2696.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate is pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D…
| Periodo | 2021-08 | 2021-05 | 2021-03 | 2020-11 |
|---|---|---|---|---|
| Real | $-44.10 | $-54.60 | $-54.60 | $-92.40 |
| Estimado | $-60.90 | $-81.90 | $-78.75 | $-91.35 |
| Sorpresa | +27.6% | +33.3% | +30.7% | -1.1% |
| Métrica | VCNX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -3117.3% | -38.6% | -3078.7% |
| Net Margin | -3100.5% | -33.6% | -3066.9% |
| FCF Margin | -2696.8% | -13.9% | -2683.0% |
| ROE | — | -40.4% | — |
| ROA | -717.8% | -32.0% | -685.8% |
| Current Ratio | 0.50 | 2.84 | -2.34 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |